Sources indicate that A newly rolled out study brings together 26 labs across the US and Europe to quantify the exact metabolic cost of neural computation. Over a 10-year initiative, researchers will investigate how energy constraints shape brain circuits and behavior, solving mysteries such as why active brains shift toward fast, inefficient glycolysis and how glia and neuromodulators support neurons during intense cognitive demand or oxygen deprivation.

Source: Boston University / Simons Foundation.

According to recent reports, constructing a house without knowing the cost of materials, labor, or individual rooms would make architectural planning impossible. Yet for decades, neuroscientists attempting to decode how the brain processes information have operated without a quantitative metabolic blueprint. While researchers have mapped neural wiring and electrical firing patterns in exquisite detail, the exact energetic cost of thought, how much fuel the brain produces, distributes, and burns to execute specific computations, has remained largely unquantified.

To establish this foundational accounting, the Simons Foundation has launched the Simons Collaboration on Brain Energetics (SCOBE), an ambitious, decade-long international consortium uniting 26 laboratories across the United States and Europe.

In a recent development, co-led by Dr. Anna Devor, professor of biomedical engineering at Boston University College of Engineering, and Dr. Tom Clandinin, professor of neurobiology at Stanford University, the initiative seeks to determine how strict bioenergetic limits govern neural computation from individual molecules up to whole-brain behavior.

Industry observers note that “There are lots of really cool energetics questions, but most of them are completely unanswered,” explained Dr. Devor, whose Boston University laboratory will receive $3.2 million over the next ten years as part of the program. “For example, nobody understands how the brain’s computational principles are constrained by the availability of energetic resources and how that works.”.

In a recent development, every electrical impulse, synaptic release, and molecular pump in the central nervous system runs on adenosine triphosphate (ATP), the universal energy currency of living cells. Despite its fundamental role, neurobiology lacks a precise mathematical ledger detailing how much ATP different types of neural networks require to store memories, process sensory inputs, or make decisions.

“Energetics is everything,” Devor emphasized. “Our basic brain activity cannot happen unless the brain utilizes ATP, and we don’t really understand and don’t have a quantitative account of how much ATP different types of computations in the brain utilize.”.

One of the central mysteries SCOBE investigators will tackle is a metabolic shift known as aerobic glycolysis. Under baseline resting conditions, brain cells burn glucose efficiently using oxygen inside mitochondria—the cell’s high-yield power stations. However, the moment neurons become actively engaged in a demanding cognitive task, the brain abruptly begins consuming far more sugar than can be oxidized by mitochondria, routing glucose through rapid, mitochondria-independent glycolysis.

Devor highlights two primary hypotheses driving this phenomenon:.

Industry observers note that “These ideas are not new, but testing it experimentally requires new research tools and quantitative models. Our SCOBE consortium is perfectly positioned to deliver both,” Devor noted.

In a recent development, furthermore, the team will investigate the upstream chemical switches that turn up this metabolic dial during moments of focus and alertness. Researchers suspect that norepinephrine, a neuromodulator closely related to adrenaline that heightens arousal and cognitive acuity, directly triggers rapid glycolysis upregulation to meet sudden computational loads.

Because the brain lacks substantial internal fuel reserves, it depends on continuous vascular delivery of glucose and oxygen. Consequently, even microscopic disruptions, such as blood flow stoppages in single capillaries, can starve local neurons. Such capillary dysfunction and silent microstrokes are pervasive features of biological aging and neurodegenerative disorders like Alzheimer’s disease.

Paradoxically, clinical and experimental studies have also documented remarkable instances where neurons recover full cellular function following prolonged periods of oxygen deprivation, suggesting the brain possesses hidden metabolic survival mechanisms that remain poorly understood.

Unraveling these residual metabolic pathways could yield major breakthroughs in emergency medicine, guiding improved neuroprotective protocols for resuscitation following cardiac arrest or acute ischemic stroke.

Backed by the Simons Foundation’s 10-year funding horizon, double the duration of standard federal grants, and dedicated high-performance computational infrastructure to share massive neurophotonic imaging datasets across partner labs in the U.S., Norway, and Austria, SCOBE aims to build the first comprehensive energetic blueprint of the thinking brain.

What is the Simons Collaboration on Brain Energetics (SCOBE)?

SCOBE is a 10-year international research consortium comprising 26 labs across the US and Europe, co-led by Anna Devor (Boston University) and Tom Clandinin (Stanford University). Its goal is to quantify the exact energy (ATP) costs of brain computation from the molecular level up to complex behavior.

Why does the brain switch to inefficient energy production when thinking hard?

During active cognitive tasks, the brain consumes extra sugar using glycolysis, a process that yields less ATP per sugar molecule than mitochondria, but operates much faster. Researchers are testing whether the brain trades efficiency for speed, or whether supportive glial cells consume this sugar to fuel active neurons.

How could mapping brain energetics improve medical treatments?

Understanding how brain cells produce energy and survive temporary oxygen shortages could lead to better treatments for stroke, microvascular aging, and neurodegenerative diseases, while improving emergency resuscitation strategies after cardiac arrest.

→ Read original article